A former U.S. senator says she’s personally spoken to the heads of the U.S. Department of Health and Human Services (HHS) and U.S. Department of Veterans Affairs (VA) about the therapeutic potential of psychedelics like ibogaine—and both members of President Donald Trump’s cabinet were receptive to reform on the issue.
Former Sen. Kyrsten Sinema (I-AZ), who served as a Democrat for most of her career in Congress before becoming an independent, said there’s a unique opportunity under the Trump administration to free up access to psychedelics for therapeutic purposes, citing her “close” relationship to the HHS Secretary Robert F. Kennedy Jr. and shifting political views around the alternative therapies.
Sinema spoke in an interview with Politico about the “magical, unique time” the country is at with respect to psychedelics reform during a recent event organized by Americans for Ibogaine, an advocacy organization co-founded by former Texas Gov. Rick Perry (R).
“Is there an opportunity to get this done in this administration? Heck, yeah,” she said, adding that Kennedy “is a disruptor and he supports psychedelic medicine.”
“The possibility is ripe in this administration, and we should strike while the iron is hot,” the former lawmaker, who’s disclosed her own therapeutic
Read full article on Marijuana Moment
